Skip to main content
. 2019 Jan-Jun;9(1):49–51. doi: 10.5005/jp-journals-10018-1295

Table 1.

Lab monitorization of the patient (days indicate hospitalization and withdrawal periods)

ALT (U/L) AST (U/L) ALP (U/L) GGT (U/L) D. Bil (mg/dL) T. Bil (mg/dL) Albumin (g/dL) INR
1-year ago-first hospitalization with “probable” DILI 1256 989 156 256 5.36 7.02 - -
6 months ago-control 30 25 72 49 0.28 0.97 3.92 1.10
Day 1 4133 1630 146 399 9.06 11.86 4.68 1.12
Day 7 1524 1233 104 116 7.72 11.39 3.74 1.18
Day 14 947 395 85 91 1.83 2.93 3.89 1.07
Day 21 432 128 84 81 1.06 1.82 3.96 1.09
Day 28 122 56 76 56 0.34 1.20 4.12 1.08
Day 180 (outpatient) 28 20 68 51 0.25 0.93 - --

DILI, drug induced liver injury; ALT, alanine aminotransferase; AST, aspartat aminotransferase; ALP, alkaline phosphatase; GGT, gamma glutamyl transferase; D. Bil, direct bilirubine; T. Bil, total bilirubine; INR, international normalized ratio; U/L, units per litre; mg/dL, milligrams per decilitre; g/dL, grams per decilitre

HHS Vulnerability Disclosure